Abiopharma

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

TRF-1 mantém decisões favoráveis ao Projeto Potássio Autazes e impede o encaminhamento de recursos aos tribunais superiores do Brasil

Beyond Meat Announces 1-for-30 Reverse Stock Split

Brazil’s Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts

Terrestrial Energy Reports Second Quarter 2026 Results

Vestis Reports Third Quarter 2026 Results and Increases Full Year 2026 Outlook

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update